HISUN(SH:600267)2015-04-20 16:00Financial Performance - Operating revenue for the period was ¥2,355,724,966.27, reflecting a growth of 2.11% year-on-year[6]. - Net profit attributable to shareholders of the listed company was ¥5,058,058.95, a decrease of 93.31% compared to the same period last year[6]. - Basic earnings per share decreased by 88.89% to ¥0.01 from ¥0.09 in the previous year[6]. - The profit attributable to the parent company's shareholders in Q1 2015 was CNY 5,058,058.95, down 93.3% from CNY 75,587,178.66 in the previous year[29]. - Net profit for Q1 2015 was CNY 41,678,036.99, a decrease of 70.4% compared to CNY 140,948,205.36 in Q1 2014[29]. - The total comprehensive income for Q1 2015 was CNY 41,540,932.60, down from CNY 139,594,010.28 in Q1 2014[30]. Cash Flow - Cash flow from operating activities increased significantly by 334.22% to ¥163,749,236.24 compared to the same period last year[6]. - Cash generated from operating activities in Q1 2015 was CNY 2,720,211,995.89, an increase of 11.0% from CNY 2,449,495,969.92 in Q1 2014[35]. - The net cash flow from operating activities was 163,749,236.24 RMB, a significant increase from 37,710,750.39 RMB in the previous period, reflecting a growth of approximately 334%[36]. - The total cash inflow from operating activities was 703,844,516.86 RMB, slightly lower than 734,930,934.73 RMB in the previous period, showing a decrease of about 4%[39]. - The net cash flow from operating activities was 18,309,637.27 RMB, down from 22,543,357.16 RMB in the previous period, reflecting a decrease of approximately 19%[39]. Assets and Liabilities - Total assets at the end of the reporting period reached ¥17,444,486,297.57, an increase of 0.85% compared to the end of the previous year[6]. - Total current assets decreased from ¥6,913,940,363.67 to ¥6,681,626,569.84, a decline of approximately 3.35%[20]. - Total non-current assets increased from ¥10,384,363,350.03 to ¥10,762,859,727.73, reflecting a growth of about 3.63%[21]. - Total liabilities increased from ¥9,033,647,132.13 to ¥9,138,288,783.37, a rise of approximately 1.16%[22]. - Total equity increased from ¥8,264,656,581.57 to ¥8,306,197,514.20, a rise of about 0.50%[22]. Shareholder Information - The total number of shareholders at the end of the reporting period was 32,019[11]. - Zhejiang Haizheng Group Co., Ltd. held 33.22% of the shares, making it the largest shareholder[11]. Investments and Acquisitions - The company approved a financial assistance agreement with its controlling shareholder for up to ¥400 million, with ¥245 million principal outstanding as of the report date[15]. - The company agreed to acquire 68% of Yunnan Biopharmaceutical Co., Ltd. for a total price of ¥150.96 million[15]. - The company approved an investment of $625,000 to acquire 22.04% of Fomotech's preferred shares[16]. - A subsidiary will establish a wholly-owned subsidiary in the U.S. with an investment of $5 million[17]. Other Financial Metrics - The weighted average return on net assets dropped to 0.072%, a decrease of 1.463 percentage points year-on-year[6]. - Investment income surged by 609.48% to ¥9,993,408.46 driven by increased net income from associated companies[14]. - The company reported a non-operating income of ¥3,778,768.45 from government subsidies closely related to its normal business operations[8]. - Accounts receivable decreased by 31.43% to ¥144,170,055.97 due to an increase in endorsed notes[13]. - Other receivables increased by 174.87% to ¥165,937,381.65 primarily due to increased prepayments for investments[13]. - Prepayments increased by 52.82% to ¥30,594,992.50 as a result of increased advance payments received[14]. - Employee compensation payable decreased by 36.08% to ¥166,034,213.91 due to payments made for the previous year's salaries[14].